
1001 - 5000 funcionários
💊 Farmacêutico
🏥 Saúde
🧬 Biotecnologia
Pharmaceuticals • Healthcare • Biotechnology
As Empresas Farmacêuticas Otsuka (EUA) são um ator proeminente na indústria de fabricação farmacêutica, dedicadas a criar produtos inovadores para uma melhor saúde em todo o mundo. A empresa é composta por duas entidades principais: a Otsuka America Pharmaceutical, Inc. (OAPI), que se concentra na comercialização de produtos descobertos e licenciados pela Otsuka na América do Norte, e a Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), que é especializada no desenvolvimento clínico e registro global de soluções inovadoras em saúde, particularmente na área de neurociências.
🕒 Outubro 21
🇺🇸 Estados Unidos – Remoto (EUA)
💵 $186.489 - $278.875 / ano
⏰ Tempo Integral
🔴 Especialista
👔 Diretor
👻 Score fantasma 0%
🗣️🇺🇸🇬🇧 Inglês obrigatório
De onde vem esta vaga
Publicada na página de carreiras da Otsuka Pharmaceutical Companies (U.S.) ↗, não em um site de vagas
Vista pela primeira vez pelo Remote Rocketship Outubro 21
Ainda aberta no site da Otsuka Pharmaceutical Companies (U.S.). Verificada 3 horas atrás.

1001 - 5000 funcionários
💊 Farmacêutico
🏥 Saúde
🧬 Biotecnologia
Pharmaceuticals • Healthcare • Biotechnology
As Empresas Farmacêuticas Otsuka (EUA) são um ator proeminente na indústria de fabricação farmacêutica, dedicadas a criar produtos inovadores para uma melhor saúde em todo o mundo. A empresa é composta por duas entidades principais: a Otsuka America Pharmaceutical, Inc. (OAPI), que se concentra na comercialização de produtos descobertos e licenciados pela Otsuka na América do Norte, e a Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), que é especializada no desenvolvimento clínico e registro global de soluções inovadoras em saúde, particularmente na área de neurociências.
• Lead activities related to Early Clinical Development supporting Otsuka’s discovery and early-phase pipeline • Own end-to-end early clinical development strategy and execution for the early-phase portfolio, with emphasis on CNS • Shape program strategy from indication selection through pre-IND, first-in-human, proof of concept, and go/no-go decisions • Integrate discovery, nonclinical, clinical pharmacology, regulatory, and commercial functions • Serve as scientific and clinical expert in CNS translational medicine and early clinical development • Serve as ECD lead on development teams for multiple assets • Drive Research-to-Development strategies and stage-gate decision-making • Prepare and present decision-quality data packages for internal governance reviews • Evaluate new compounds, molecular and biological targets, and formulation technologies • Partner with research organizations to advance early- and discovery-phase compounds • Engage external experts and key opinion leaders to inform translational and proof-of-concept strategy • Represent ECD in cross-functional and internal/external collaborations, including business development • Support regulatory interactions, including pre-IND and IND submissions • Lead development efforts from target identification through IND and proof of concept • Provide medical leadership for early-phase clinical protocols, informed consent forms, and investigator brochures • Monitor safety and contribute to DSMB or safety review activities • Support or lead public-private partnerships in pre-competitive settings • Promote and elevate cross-functional early development activities within the EDO • Collaborate with biomarker and digital innovation teams on biomarker-driven CNS approaches • Support team members in building translational and early clinical development expertise
• MD, MD/PhD, or PhD with subspecialty training in Clinical psychology/neuropsychology • 5+ years of translational medicine and/or early clinical development experience • Track record of advancing biologics and/or small molecules through IND and FIH/PoC • Expert understanding of industry best practices and adjacent functional areas • Ability to coordinate and guide cross-functional teams in a matrixed, global setting • Solid strategic thinking and ability to make informed decisions amid uncertainty • Outstanding communication skills • Ability to synthesize complex data and influence executive stakeholders • Preferred: MD with specialty training in psychiatry and/or neurology • Preferred: Deep expertise in CNS, particularly psychiatry, neurodegenerative disease, and/or neuroinflammation • Preferred: Experience implementing clinical study plans to drive decision-making • Preferred: Experience with external collaborations • Ability to travel 20%
• Comprehensive medical, dental, vision, and prescription drug coverage • Company-provided basic life insurance • Accidental death and dismemberment insurance • Short-term and long-term disability insurance • Tuition reimbursement • Student loan assistance • Generous 401(k) match • Flexible time off • Paid holidays • Paid leave programs • Other company-provided benefits • Incentive opportunity
Candidatar-seMelhore suas chances de conseguir uma entrevista verificando sua pontuação de currículo antes de se candidatar.
🕒 Outubro 21
Commercial director leading epilepsy KOL engagement, market intelligence, and launch readiness for Xenon Pharmaceuticals’ Azetukalner. Supporting cross-functional US commercial strategy across the Central region.
🇺🇸 Estados Unidos – Remoto (EUA)
💵 $245.000 - $270.000 / ano
💰 $300.000.000 Post-IPO Equity - Xenon Pharmaceuticals em 2023-11
⏰ Tempo Integral
🔴 Especialista
👔 Diretor
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Outubro 21
Oncology account director leading Novartis’ priority healthcare accounts across California and Nevada. Driving market access, launch strategy, executive partnerships, and cross-functional execution.
🇺🇸 Estados Unidos – Remoto (EUA)
💵 $185.500 - $344.500 / ano
⏰ Tempo Integral
🔴 Especialista
👔 Diretor
🦅 Patrocina Visto H1B
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Outubro 21
Director growing Veeam’s strategic partnerships with India-headquartered global system integrators. Leading alliance strategy, co-sell initiatives, solutions, pipeline, revenue, and a global team.
🇺🇸 Estados Unidos – Remoto (EUA)
💰 $500.000.000 Private Equity Round em 2019-01
⏰ Tempo Integral
🔴 Especialista
👔 Diretor
🦅 Patrocina Visto H1B
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Outubro 21
Managing Director founding Infinity Constellation's environmental consulting business unit. Leading client growth, compliant reporting, and AI-enabled tools for US regulatory work.
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Outubro 21
Associate Director/Director of IT shaping strategy, AI governance, and compliance at Kura Oncology, a precision oncology biopharmaceutical company. Leading transformation, security, GxP validation, budgeting, and governance.
🇺🇸 Estados Unidos – Remoto (EUA)
💵 $186.000 - $259.000 / ano
💰 $125.000.000 Post-IPO Debt em 2022-11
⏰ Tempo Integral
🔴 Especialista
👔 Diretor
🗣️🇺🇸🇬🇧 Inglês obrigatório